Cofetuzumab pelidotin
id:
cofetuzumab-pelidotin-288-2027510
title:
Cofetuzumab pelidotin
text:
Cofetuzumab pelidotin is an experimental antibody-drug conjugate in development for the treatment of cancer. It was created by Stemcentrx and is being developed by Pfizer. The drug is an anti-PTK7 monoclonal antibody linked to auristatin-0101, an auristatin microtubule inhibitor. Antibody-drug conjugates use a monoclonal antibody that binds to tumors cells linked to a cytotoxic drug that then kills the cells. This allows the drug to selectively target the cells that the antibody binds to. PTK7 i
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental cancer drug
original url:
https://en.wikipedia.org/wiki/Cofetuzumab_pelidotin
date created:
date modified:
2023-05-03T21:41:51Z
main entity:
{"identifier":"Q28456920","url":"https://www.wikidata.org/entity/Q28456920"}
image:
fields total:
13
integrity:
14